Pfizer to invest £5M in paediatric medicines
The news coincides with the Medicines Manufacturing Industry Partnership (MMIP) annual conference.
Read More
Tag: MMIP
CGT Catapult unveils major UK investment in skills and capabilities
The Cell and Gene Therapy Catapult (CGT Catapult) has announced a major investment in skills and capability training to help accelerate integration of cell and gene therapies into health services following their regulatory approval.
Read More
MMIP call for support to boost medicines manufacturing in the UK
The Medicines Manufacturing Industry Partnership (MMIP) is requesting government funds to help set up four new Centres of Excellence for medicines manufacturing across the UK, in line with wider plans to build on the exporting strengths of the country’s biopharma sector.
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
